venetoclax,quizartinib,decitabine
roche,abbvie,daiichi sankyo
['quizartinib', 'triplet', 'venetoclax', 'myeloid', 'leukemia']
quizartinib with decitabine and venetoclax (triplet) is active in patients with flt3-itd mutated acute myeloid leukemia #eha2022 
Professor of hematology, Universitary hospital of Sidi Bel Abbés.
Head, Hospitalisation and  Geriatric Unit.